durvalumab
astrazeneca
['durvalumab', 'topaz-1']
original article: durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (topaz-1), by oh et al. a phase 3 study, topaz-1, evaluated immunotherapy plus chemotherapy as first-line treatment for advanced biliary tract cancer. #asco22 
NEJM Evidence, a new journal from NEJM Group, presents innovative #OriginalResearch and fresh, bold ideas in #ClinicalTrial design and clinical decision-making.